|
DR6
|
ACADIA Pharmaceuticals Inc
|
DE
|
F
|
|
DUL
|
Alnylam Pharmaceuticals Inc
|
DE
|
F
|
|
G0F
|
GRIFOLS ADR 1/2/EO-50
|
DE
|
F
|
|
G0FB
|
Grifols S.A
|
DE
|
F
|
|
GHDN
|
Brainstorm Cell Therapeutics Inc
|
DE
|
F
|
|
IDP
|
Biogen Inc
|
DE
|
F
|
|
IGS1
|
India Globalization Capital Inc
|
DE
|
F
|
|
IMR
|
AC IMMUNE SA SF-02
|
DE
|
F
|
|
LUP
|
Luye Pharma Group Ltd
|
DE
|
F
|
|
OZTA
|
Grifols S.A
|
DE
|
F
|
|
P0J
|
APTAMER GROUP LTD LS-001
|
DE
|
F
|
|
PBN
|
Alterity Therapeutics Limited
|
DE
|
F
|
|
PHF
|
Pharmagest Interactive SA
|
DE
|
F
|
|
PX91
|
Cassava Sciences Inc
|
DE
|
F
|
|
PYPB
|
IXICO PLC LS -01
|
DE
|
F
|
|
S1R
|
Shanghai Pharmaceuticals Holding Co. Ltd
|
DE
|
F
|
|
SG7
|
Sage Therapeutics Inc
|
DE
|
F
|
|
SH0
|
Shionogi & Co. Ltd
|
DE
|
F
|
|
TE1
|
Bio-Techne Corporation
|
DE
|
F
|
|
UNC
|
UCB SA
|
DE
|
F
|